サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1109893

世界のリラグルチド原薬市場：考察と予測 (2028年まで)

Global Liraglutide API Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
世界のリラグルチド原薬市場：考察と予測 (2028年まで)
出版日: 2022年08月08日
発行: QYResearch
ページ情報: 英文 115 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、リラグルチド原薬 (Liraglutide API) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • リラグルチド原薬の製品概要
  • 市場：純度別
    • 世界のリラグルチド原薬 市場規模：純度別, 2017 VS 2021 VS 2028
    • 0.98
    • 0.99
    • 0.995
    • Others
  • 市場：アプリケーション別
    • 世界のリラグルチド原薬 市場規模：アプリケーション別, 2017 VS 2021 VS 2028
    • Injection
    • Pills
    • Others
  • 調査目的
  • 対象期間

第2章 世界のリラグルチド原薬の生産

  • 世界のリラグルチド原薬の生産能力 (2017-2028)
  • 世界のリラグルチド原薬の生産：地域別: 2017 VS 2021 VS 2028
  • 世界のリラグルチド原薬の生産：地域別
    • 世界のリラグルチド原薬の生産実績：地域別 (2017-2022)
    • 世界のリラグルチド原薬の生産予測：地域別 (2023-2028)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 世界のリラグルチド原薬の販売（数量・金額）推定および予測

  • 世界のリラグルチド原薬の販売 推定および予測 2017-2028
  • 世界のリラグルチド原薬の収益 推定および予測 2017-2028
  • 世界のリラグルチド原薬の収益：地域別: 2017 VS 2021 VS 2028
  • 世界のリラグルチド原薬の販売：地域別
    • 世界のリラグルチド原薬の販売：地域別 (2017-2022)
    • 世界の販売 リラグルチド原薬 ：地域別 (2023-2028)
  • 世界のリラグルチド原薬の収益：地域別
    • 世界のリラグルチド原薬の収益：地域別 (2017-2022)
    • 世界のリラグルチド原薬の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第4章 競合：メーカー別

  • 世界のリラグルチド原薬の生産能力：メーカー別
  • 世界のリラグルチド原薬の販売：メーカー別
    • 世界のリラグルチド原薬の販売：メーカー別 (2017-2022)
    • 世界のリラグルチド原薬の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： リラグルチド原薬2021
  • 世界のリラグルチド原薬の収益：メーカー別
    • 世界のリラグルチド原薬の収益：メーカー別 (2017-2022)
    • 世界のリラグルチド原薬の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： リラグルチド原薬の収益 2021
  • 世界のリラグルチド原薬の販売価格：メーカー別
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のリラグルチド原薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のリラグルチド原薬のメーカーの地理的分布
  • M&A, 拡張計画

第5章 市場規模：純度別

  • 世界のリラグルチド原薬の販売：純度別
    • 世界のリラグルチド原薬の販売実績：純度別 (2017-2022)
    • 世界のリラグルチド原薬の販売予測：純度別 (2023-2028)
    • 世界のリラグルチド原薬の販売市場シェア：純度別 (2017-2028)
  • 世界のリラグルチド原薬の収益：純度別
    • 世界のリラグルチド原薬の収益実績：純度別 (2017-2022)
    • 世界のリラグルチド原薬の収益予測：純度別 (2023-2028)
    • 世界のリラグルチド原薬の収益シェア：純度別 (2017-2028)
  • 世界のリラグルチド原薬の価格：純度別
    • 世界のリラグルチド原薬の価格：純度別 (2017-2022)
    • 世界のリラグルチド原薬の価格予測：純度別 (2023-2028)

第6章 市場規模：アプリケーション別

  • 世界のリラグルチド原薬の販売：アプリケーション別
    • 世界のリラグルチド原薬の販売実績：アプリケーション別 (2017-2022)
    • 世界のリラグルチド原薬の販売予測：アプリケーション別 (2023-2028)
    • 世界のリラグルチド原薬の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のリラグルチド原薬の収益：アプリケーション別
    • 世界のリラグルチド原薬の収益実績：アプリケーション別 (2017-2022)
    • 世界のリラグルチド原薬の収益予測：アプリケーション別 (2023-2028)
    • 世界のリラグルチド原薬の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のリラグルチド原薬の価格：アプリケーション別
    • 世界のリラグルチド原薬の価格：アプリケーション別 (2017-2022)
    • 世界のリラグルチド原薬の価格予測：アプリケーション別 (2023-2028)

第7章 北米

  • 北米のリラグルチド原薬 市場規模：純度別
    • 北米のリラグルチド原薬の販売：純度別 (2017-2028)
    • 北米のリラグルチド原薬の収益：純度別 (2017-2028)
  • 北米のリラグルチド原薬 市場規模：アプリケーション別
    • 北米のリラグルチド原薬の販売：アプリケーション別 (2017-2028)
    • 北米のリラグルチド原薬の収益：アプリケーション別 (2017-2028)
  • 北米のリラグルチド原薬の販売：国別
    • 北米のリラグルチド原薬の販売：国別 (2017-2028)
    • 北米のリラグルチド原薬の収益：国別 (2017-2028)
    • 米国
    • カナダ

第8章 欧州

  • 欧州のリラグルチド原薬 市場規模：純度別
    • 欧州のリラグルチド原薬の販売：純度別 (2017-2028)
    • 欧州のリラグルチド原薬の収益：純度別 (2017-2028)
  • 欧州のリラグルチド原薬 市場規模：アプリケーション別
    • 欧州のリラグルチド原薬の販売：アプリケーション別 (2017-2028)
    • 欧州のリラグルチド原薬の収益：アプリケーション別 (2017-2028)
  • 欧州のリラグルチド原薬の販売：国別
    • 欧州のリラグルチド原薬の販売：国別 (2017-2028)
    • 欧州のリラグルチド原薬の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 アジア太平洋

  • アジア太平洋のリラグルチド原薬 市場規模：純度別
    • アジア太平洋のリラグルチド原薬の販売：純度別 (2017-2028)
    • アジア太平洋のリラグルチド原薬の収益：純度別 (2017-2028)
  • アジア太平洋のリラグルチド原薬 市場規模：アプリケーション別
    • アジア太平洋のリラグルチド原薬の販売：アプリケーション別 (2017-2028)
    • アジア太平洋のリラグルチド原薬の収益：アプリケーション別 (2017-2028)
  • アジア太平洋のリラグルチド原薬の販売：地域別
    • アジア太平洋のリラグルチド原薬の販売：地域別 (2017-2028)
    • アジア太平洋のリラグルチド原薬の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第10章 ラテンアメリカ

  • ラテンアメリカのリラグルチド原薬 市場規模：純度別
    • ラテンアメリカのリラグルチド原薬の販売：純度別 (2017-2028)
    • ラテンアメリカのリラグルチド原薬の収益：純度別 (2017-2028)
  • ラテンアメリカのリラグルチド原薬 市場規模：アプリケーション別
    • ラテンアメリカのリラグルチド原薬の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのリラグルチド原薬の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのリラグルチド原薬の販売：国別
    • ラテンアメリカのリラグルチド原薬の販売：国別 (2017-2028)
    • ラテンアメリカのリラグルチド原薬の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカ

  • 中東・アフリカのリラグルチド原薬 市場規模：純度別
    • 中東・アフリカのリラグルチド原薬の販売：純度別 (2017-2028)
    • 中東・アフリカのリラグルチド原薬の収益：純度別 (2017-2028)
  • 中東・アフリカのリラグルチド原薬 市場規模：アプリケーション別
    • 中東・アフリカのリラグルチド原薬の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのリラグルチド原薬の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのリラグルチド原薬の販売：国別
    • 中東・アフリカのリラグルチド原薬の販売：国別 (2017-2028)
    • 中東・アフリカのリラグルチド原薬の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • UAE

第12章 企業プロファイル

  • Suzhou Tianma Pharma Group
  • Chengdu Shengnuo Biopharm
  • Hangzhou Jiuyuan Gene Engineering
  • Hybio Pharmaceutical
  • Dr. Reddy's Laboratories
  • Rochem International Inc
  • ChemWerth Inc
  • Bachem AG
  • CBL- Chemical and Biopharmaceutical Laboratories
  • AmbioPharm
  • Piramal Pharma Solutions
  • ALP Pharm
  • Amphastar Pharmaceuticals
  • Amuna Pharmaceuticals LLP
  • Anthem Biosciences
  • Aurobindo Pharma Limited
  • Fresenius SE & Co. KGaA

第13章 業界チェーンと販売チャネルの分析

  • リラグルチド原薬 業界チェーン分析
  • リラグルチド原薬 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • リラグルチド原薬 生産形態とプロセス
  • リラグルチド原薬 販売およびマーケティング
    • リラグルチド原薬 販売チャネル
    • リラグルチド原薬 卸業者
  • リラグルチド原薬 顧客

第14章 市場の促進要因, 機会, 課題とリスク要因の分析

  • リラグルチド原薬 業界動向
  • リラグルチド原薬 市場の促進要因
  • リラグルチド原薬 市場の課題
  • リラグルチド原薬 市場の抑制要因

第15章 世界のリラグルチド原薬の主な市場調査結果

第16章 付録

図表

List of Tables

  • Table 1. Global Liraglutide API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of 0.98
  • Table 3. Major Manufacturers of 0.99
  • Table 4. Major Manufacturers of 0.995
  • Table 5. Major Manufacturers of Others
  • Table 6. Global Liraglutide API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
  • Table 7. Global Liraglutide API Production by Region: 2017 VS 2021 VS 2028 (Tons)
  • Table 8. Global Liraglutide API Production by Region (2017-2022) & (Tons)
  • Table 9. Global Liraglutide API Production Market Share by Region (2017-2022)
  • Table 10. Global Liraglutide API Production by Region (2023-2028) & (Tons)
  • Table 11. Global Liraglutide API Production Market Share by Region (2023-2028)
  • Table 12. Global Liraglutide API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 13. Global Liraglutide API Sales by Region (2017-2022) & (Tons)
  • Table 14. Global Liraglutide API Sales Market Share by Region (2017-2022)
  • Table 15. Global Liraglutide API Sales by Region (2023-2028) & (Tons)
  • Table 16. Global Liraglutide API Sales Market Share by Region (2023-2028)
  • Table 17. Global Liraglutide API Revenue by Region (2017-2022) & (US$ Million)
  • Table 18. Global Liraglutide API Revenue Market Share by Region (2017-2022)
  • Table 19. Global Liraglutide API Revenue by Region (2023-2028) & (US$ Million)
  • Table 20. Global Liraglutide API Revenue Market Share by Region (2023-2028)
  • Table 21. Global Liraglutide API Production Capacity by Manufacturers (2017-2022) & (Tons)
  • Table 22. Global Liraglutide API Capacity Market Share by Manufacturers (2017-2022)
  • Table 23. Global Liraglutide API Sales by Manufacturers (2017-2022) & (Tons)
  • Table 24. Global Liraglutide API Sales Market Share by Manufacturers (2017-2022)
  • Table 25. Global Liraglutide API Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 26. Global Liraglutide API Revenue Share by Manufacturers (2017-2022)
  • Table 27. Liraglutide API Price by Manufacturers 2017-2022 (US$/Kg)
  • Table 28. Global Liraglutide API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 29. Global Liraglutide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide API as of 2021)
  • Table 30. Liraglutide API Manufacturing Base Distribution and Headquarters
  • Table 31. Manufacturers Liraglutide API Product Offered
  • Table 32. Date of Manufacturers Enter into Liraglutide API Market
  • Table 33. Mergers & Acquisitions, Expansion Plans
  • Table 34. Global Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 35. Global Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 36. Global Liraglutide API Sales Share by Purity (2017-2022)
  • Table 37. Global Liraglutide API Sales Share by Purity (2023-2028)
  • Table 38. Global Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 39. Global Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 40. Global Liraglutide API Revenue Share by Purity (2017-2022)
  • Table 41. Global Liraglutide API Revenue Share by Purity (2023-2028)
  • Table 42. Liraglutide API Price by Purity (2017-2022) & (US$/Kg)
  • Table 43. Global Liraglutide API Price Forecast by Purity (2023-2028) & (US$/Kg)
  • Table 44. Global Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 45. Global Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 46. Global Liraglutide API Sales Share by Application (2017-2022)
  • Table 47. Global Liraglutide API Sales Share by Application (2023-2028)
  • Table 48. Global Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 49. Global Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 50. Global Liraglutide API Revenue Share by Application (2017-2022)
  • Table 51. Global Liraglutide API Revenue Share by Application (2023-2028)
  • Table 52. Liraglutide API Price by Application (2017-2022) & (US$/Kg)
  • Table 53. Global Liraglutide API Price Forecast by Application (2023-2028) & (US$/Kg)
  • Table 54. North America Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 55. North America Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 56. North America Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 57. North America Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 58. North America Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 59. North America Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 60. North America Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 61. North America Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 62. North America Liraglutide API Sales by Country (2017-2022) & (Tons)
  • Table 63. North America Liraglutide API Sales by Country (2023-2028) & (Tons)
  • Table 64. North America Liraglutide API Revenue by Country (2017-2022) & (US$ Million)
  • Table 65. North America Liraglutide API Revenue by Country (2023-2028) & (US$ Million)
  • Table 66. Europe Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 67. Europe Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 68. Europe Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 69. Europe Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 70. Europe Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 71. Europe Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 72. Europe Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 73. Europe Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 74. Europe Liraglutide API Sales by Country (2017-2022) & (Tons)
  • Table 75. Europe Liraglutide API Sales by Country (2023-2028) & (Tons)
  • Table 76. Europe Liraglutide API Revenue by Country (2017-2022) & (US$ Million)
  • Table 77. Europe Liraglutide API Revenue by Country (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 79. Asia Pacific Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 80. Asia Pacific Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 82. Asia Pacific Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 83. Asia Pacific Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 84. Asia Pacific Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 85. Asia Pacific Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 86. Asia Pacific Liraglutide API Sales by Region (2017-2022) & (Tons)
  • Table 87. Asia Pacific Liraglutide API Sales by Region (2023-2028) & (Tons)
  • Table 88. Asia Pacific Liraglutide API Revenue by Region (2017-2022) & (US$ Million)
  • Table 89. Asia Pacific Liraglutide API Revenue by Region (2023-2028) & (US$ Million)
  • Table 90. Latin America Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 91. Latin America Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 92. Latin America Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 93. Latin America Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 94. Latin America Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 95. Latin America Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 96. Latin America Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 97. Latin America Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 98. Latin America Liraglutide API Sales by Country (2017-2022) & (Tons)
  • Table 99. Latin America Liraglutide API Sales by Country (2023-2028) & (Tons)
  • Table 100. Latin America Liraglutide API Revenue by Country (2017-2022) & (US$ Million)
  • Table 101. Latin America Liraglutide API Revenue by Country (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Liraglutide API Sales by Purity (2017-2022) & (Tons)
  • Table 103. Middle East and Africa Liraglutide API Sales by Purity (2023-2028) & (Tons)
  • Table 104. Middle East and Africa Liraglutide API Revenue by Purity (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Liraglutide API Revenue by Purity (2023-2028) & (US$ Million)
  • Table 106. Middle East and Africa Liraglutide API Sales by Application (2017-2022) & (Tons)
  • Table 107. Middle East and Africa Liraglutide API Sales by Application (2023-2028) & (Tons)
  • Table 108. Middle East and Africa Liraglutide API Revenue by Application (2017-2022) & (US$ Million)
  • Table 109. Middle East and Africa Liraglutide API Revenue by Application (2023-2028) & (US$ Million)
  • Table 110. Middle East and Africa Liraglutide API Sales by Country (2017-2022) & (Tons)
  • Table 111. Middle East and Africa Liraglutide API Sales by Country (2023-2028) & (Tons)
  • Table 112. Middle East and Africa Liraglutide API Revenue by Country (2017-2022) & (US$ Million)
  • Table 113. Middle East and Africa Liraglutide API Revenue by Country (2023-2028) & (US$ Million)
  • Table 114. Suzhou Tianma Pharma Group Corporation Information
  • Table 115. Suzhou Tianma Pharma Group Description and Major Businesses
  • Table 116. Suzhou Tianma Pharma Group Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 117. Suzhou Tianma Pharma Group Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 118. Suzhou Tianma Pharma Group Recent Development
  • Table 119. Chengdu Shengnuo Biopharm Corporation Information
  • Table 120. Chengdu Shengnuo Biopharm Description and Major Businesses
  • Table 121. Chengdu Shengnuo Biopharm Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 122. Chengdu Shengnuo Biopharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 123. Chengdu Shengnuo Biopharm Recent Development
  • Table 124. Hangzhou Jiuyuan Gene Engineering Corporation Information
  • Table 125. Hangzhou Jiuyuan Gene Engineering Description and Major Businesses
  • Table 126. Hangzhou Jiuyuan Gene Engineering Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 127. Hangzhou Jiuyuan Gene Engineering Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 128. Hangzhou Jiuyuan Gene Engineering Recent Development
  • Table 129. Hybio Pharmaceutical Corporation Information
  • Table 130. Hybio Pharmaceutical Description and Major Businesses
  • Table 131. Hybio Pharmaceutical Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 132. Hybio Pharmaceutical Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 133. Hybio Pharmaceutical Recent Development
  • Table 134. Dr. Reddy's Laboratories Corporation Information
  • Table 135. Dr. Reddy's Laboratories Description and Major Businesses
  • Table 136. Dr. Reddy's Laboratories Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 137. Dr. Reddy's Laboratories Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 138. Dr. Reddy's Laboratories Recent Development
  • Table 139. Rochem International Inc Corporation Information
  • Table 140. Rochem International Inc Description and Major Businesses
  • Table 141. Rochem International Inc Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 142. Rochem International Inc Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. Rochem International Inc Recent Development
  • Table 144. ChemWerth Inc Corporation Information
  • Table 145. ChemWerth Inc Description and Major Businesses
  • Table 146. ChemWerth Inc Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 147. ChemWerth Inc Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. ChemWerth Inc Recent Development
  • Table 149. Bachem AG Corporation Information
  • Table 150. Bachem AG Description and Major Businesses
  • Table 151. Bachem AG Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 152. Bachem AG Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 153. Bachem AG Recent Development
  • Table 154. CBL- Chemical and Biopharmaceutical Laboratories Corporation Information
  • Table 155. CBL- Chemical and Biopharmaceutical Laboratories Description and Major Businesses
  • Table 156. CBL- Chemical and Biopharmaceutical Laboratories Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 157. CBL- Chemical and Biopharmaceutical Laboratories Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 158. CBL- Chemical and Biopharmaceutical Laboratories Recent Development
  • Table 159. AmbioPharm Corporation Information
  • Table 160. AmbioPharm Description and Major Businesses
  • Table 161. AmbioPharm Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 162. AmbioPharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 163. AmbioPharm Recent Development
  • Table 164. Piramal Pharma Solutions Corporation Information
  • Table 165. Piramal Pharma Solutions Description and Major Businesses
  • Table 166. Piramal Pharma Solutions Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 167. Piramal Pharma Solutions Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 168. Piramal Pharma Solutions Recent Development
  • Table 169. ALP Pharm Corporation Information
  • Table 170. ALP Pharm Description and Major Businesses
  • Table 171. ALP Pharm Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 172. ALP Pharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 173. ALP Pharm Recent Development
  • Table 174. Amphastar Pharmaceuticals Corporation Information
  • Table 175. Amphastar Pharmaceuticals Description and Major Businesses
  • Table 176. Amphastar Pharmaceuticals Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 177. Amphastar Pharmaceuticals Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 178. Amphastar Pharmaceuticals Recent Development
  • Table 179. Amuna Pharmaceuticals LLP Corporation Information
  • Table 180. Amuna Pharmaceuticals LLP Description and Major Businesses
  • Table 181. Amuna Pharmaceuticals LLP Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 182. Amuna Pharmaceuticals LLP Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 183. Amuna Pharmaceuticals LLP Recent Development
  • Table 184. Anthem Biosciences Corporation Information
  • Table 185. Anthem Biosciences Description and Major Businesses
  • Table 186. Anthem Biosciences Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 187. Anthem Biosciences Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 188. Anthem Biosciences Recent Development
  • Table 189. Aurobindo Pharma Limited Corporation Information
  • Table 190. Aurobindo Pharma Limited Description and Major Businesses
  • Table 191. Aurobindo Pharma Limited Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 192. Aurobindo Pharma Limited Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 193. Aurobindo Pharma Limited Recent Development
  • Table 194. Fresenius SE & Co. KGaA Corporation Information
  • Table 195. Fresenius SE & Co. KGaA Description and Major Businesses
  • Table 196. Fresenius SE & Co. KGaA Liraglutide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 197. Fresenius SE & Co. KGaA Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 198. Fresenius SE & Co. KGaA Recent Development
  • Table 199. Key Raw Materials Lists
  • Table 200. Raw Materials Key Suppliers Lists
  • Table 201. Liraglutide API Distributors List
  • Table 202. Liraglutide API Customers List
  • Table 203. Liraglutide API Market Trends
  • Table 204. Liraglutide API Market Drivers
  • Table 205. Liraglutide API Market Challenges
  • Table 206. Liraglutide API Market Restraints
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Liraglutide API Product Picture
  • Figure 2. Global Liraglutide API Market Share by Purity in 2021 & 2028
  • Figure 3. 0.98 Product Picture
  • Figure 4. 0.99 Product Picture
  • Figure 5. 0.995 Product Picture
  • Figure 6. Others Product Picture
  • Figure 7. Global Liraglutide API Market Share by Application in 2021 & 2028
  • Figure 8. Injection
  • Figure 9. Pills
  • Figure 10. Others
  • Figure 11. Liraglutide API Report Years Considered
  • Figure 12. Global Liraglutide API Capacity, Production and Utilization (2017-2028) & (Tons)
  • Figure 13. Global Liraglutide API Production Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Liraglutide API Production Market Share by Region (2017-2022)
  • Figure 15. Global Liraglutide API Production Market Share by Region (2023-2028)
  • Figure 16. Liraglutide API Production Growth Rate in North America (2017-2028) & (Tons)
  • Figure 17. Liraglutide API Production Growth Rate in Europe (2017-2028) & (Tons)
  • Figure 18. Liraglutide API Production Growth Rate in China (2017-2028) & (Tons)
  • Figure 19. Liraglutide API Production Growth Rate in Japan (2017-2028) & (Tons)
  • Figure 20. Global Liraglutide API Sales 2017-2028 (Tons)
  • Figure 21. Global Liraglutide API Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 22. Global Liraglutide API Revenue 2017-2028 (US$ Million)
  • Figure 23. Global Liraglutide API Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 24. Global Liraglutide API Sales Market Share by Region (2017-2022)
  • Figure 25. Global Liraglutide API Sales Market Share by Region (2023-2028)
  • Figure 26. North America Liraglutide API Sales YoY (2017-2028) & (Tons)
  • Figure 27. North America Liraglutide API Revenue YoY (2017-2028) & (US$ Million)
  • Figure 28. Europe Liraglutide API Sales YoY (2017-2028) & (Tons)
  • Figure 29. Europe Liraglutide API Revenue YoY (2017-2028) & (US$ Million)
  • Figure 30. Asia-Pacific Liraglutide API Sales YoY (2017-2028) & (Tons)
  • Figure 31. Asia-Pacific Liraglutide API Revenue YoY (2017-2028) & (US$ Million)
  • Figure 32. Latin America Liraglutide API Sales YoY (2017-2028) & (Tons)
  • Figure 33. Latin America Liraglutide API Revenue YoY (2017-2028) & (US$ Million)
  • Figure 34. Middle East & Africa Liraglutide API Sales YoY (2017-2028) & (Tons)
  • Figure 35. Middle East & Africa Liraglutide API Revenue YoY (2017-2028) & (US$ Million)
  • Figure 36. The Liraglutide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 37. The Top 5 and 10 Largest Manufacturers of Liraglutide API in the World: Market Share by Liraglutide API Revenue in 2021
  • Figure 38. Liraglutide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 39. Global Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 40. Global Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 41. Global Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 42. Global Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 43. North America Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 44. North America Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 45. North America Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 46. North America Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 47. North America Liraglutide API Sales Share by Country (2017-2028)
  • Figure 48. North America Liraglutide API Revenue Share by Country (2017-2028)
  • Figure 49. United States Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 50. Canada Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 51. Europe Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 52. Europe Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 53. Europe Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 54. Europe Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 55. Europe Liraglutide API Sales Share by Country (2017-2028)
  • Figure 56. Europe Liraglutide API Revenue Share by Country (2017-2028)
  • Figure 57. Germany Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 58. France Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 59. U.K. Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 60. Italy Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 61. Russia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 62. Asia Pacific Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 63. Asia Pacific Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 64. Asia Pacific Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 65. Asia Pacific Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 66. Asia Pacific Liraglutide API Sales Share by Region (2017-2028)
  • Figure 67. Asia Pacific Liraglutide API Revenue Share by Region (2017-2028)
  • Figure 68. China Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 69. Japan Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 70. South Korea Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 71. India Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 72. Australia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 73. China Taiwan Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 74. Indonesia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 75. Thailand Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 76. Malaysia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 77. Latin America Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 78. Latin America Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 79. Latin America Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 80. Latin America Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 81. Latin America Liraglutide API Sales Share by Country (2017-2028)
  • Figure 82. Latin America Liraglutide API Revenue Share by Country (2017-2028)
  • Figure 83. Mexico Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 84. Brazil Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 85. Argentina Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 86. Colombia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 87. Middle East and Africa Liraglutide API Sales Market Share by Purity (2017-2028)
  • Figure 88. Middle East and Africa Liraglutide API Revenue Market Share by Purity (2017-2028)
  • Figure 89. Middle East and Africa Liraglutide API Sales Market Share by Application (2017-2028)
  • Figure 90. Middle East and Africa Liraglutide API Revenue Market Share by Application (2017-2028)
  • Figure 91. Middle East and Africa Liraglutide API Sales Share by Country (2017-2028)
  • Figure 92. Middle East and Africa Liraglutide API Revenue Share by Country (2017-2028)
  • Figure 93. Turkey Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 94. Saudi Arabia Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 95. UAE Liraglutide API Revenue (2017-2028) & (US$ Million)
  • Figure 96. Liraglutide API Value Chain
  • Figure 97. Liraglutide API Production Process
  • Figure 98. Channels of Distribution
  • Figure 99. Distributors Profiles
  • Figure 100. Bottom-up and Top-down Approaches for This Report
  • Figure 101. Data Triangulation
  • Figure 102. Key Executives Interviewed
目次

This research report focuses on the Liraglutide API Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Liraglutide API Product Introduction
  • 1.2 Market by Purity
    • 1.2.1 Global Liraglutide API Market Size by Purity, 2017 VS 2021 VS 2028
    • 1.2.2 0.98
    • 1.2.3 0.99
    • 1.2.4 0.995
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Liraglutide API Market Size by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Injection
    • 1.3.3 Pills
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Liraglutide API Production

  • 2.1 Global Liraglutide API Production Capacity (2017-2028)
  • 2.2 Global Liraglutide API Production by Region: 2017 VS 2021 VS 2028
  • 2.3 Global Liraglutide API Production by Region
    • 2.3.1 Global Liraglutide API Historic Production by Region (2017-2022)
    • 2.3.2 Global Liraglutide API Forecasted Production by Region (2023-2028)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Global Liraglutide API Sales in Volume & Value Estimates and Forecasts

  • 3.1 Global Liraglutide API Sales Estimates and Forecasts 2017-2028
  • 3.2 Global Liraglutide API Revenue Estimates and Forecasts 2017-2028
  • 3.3 Global Liraglutide API Revenue by Region: 2017 VS 2021 VS 2028
  • 3.4 Global Liraglutide API Sales by Region
    • 3.4.1 Global Liraglutide API Sales by Region (2017-2022)
    • 3.4.2 Global Sales Liraglutide API by Region (2023-2028)
  • 3.5 Global Liraglutide API Revenue by Region
    • 3.5.1 Global Liraglutide API Revenue by Region (2017-2022)
    • 3.5.2 Global Liraglutide API Revenue by Region (2023-2028)
  • 3.6 North America
  • 3.7 Europe
  • 3.8 Asia-Pacific
  • 3.9 Latin America
  • 3.10 Middle East & Africa

4 Competition by Manufactures

  • 4.1 Global Liraglutide API Production Capacity by Manufacturers
  • 4.2 Global Liraglutide API Sales by Manufacturers
    • 4.2.1 Global Liraglutide API Sales by Manufacturers (2017-2022)
    • 4.2.2 Global Liraglutide API Sales Market Share by Manufacturers (2017-2022)
    • 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Liraglutide API in 2021
  • 4.3 Global Liraglutide API Revenue by Manufacturers
    • 4.3.1 Global Liraglutide API Revenue by Manufacturers (2017-2022)
    • 4.3.2 Global Liraglutide API Revenue Market Share by Manufacturers (2017-2022)
    • 4.3.3 Global Top 10 and Top 5 Companies by Liraglutide API Revenue in 2021
  • 4.4 Global Liraglutide API Sales Price by Manufacturers
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Liraglutide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.5.3 Global Liraglutide API Manufacturers Geographical Distribution
  • 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Purity

  • 5.1 Global Liraglutide API Sales by Purity
    • 5.1.1 Global Liraglutide API Historical Sales by Purity (2017-2022)
    • 5.1.2 Global Liraglutide API Forecasted Sales by Purity (2023-2028)
    • 5.1.3 Global Liraglutide API Sales Market Share by Purity (2017-2028)
  • 5.2 Global Liraglutide API Revenue by Purity
    • 5.2.1 Global Liraglutide API Historical Revenue by Purity (2017-2022)
    • 5.2.2 Global Liraglutide API Forecasted Revenue by Purity (2023-2028)
    • 5.2.3 Global Liraglutide API Revenue Market Share by Purity (2017-2028)
  • 5.3 Global Liraglutide API Price by Purity
    • 5.3.1 Global Liraglutide API Price by Purity (2017-2022)
    • 5.3.2 Global Liraglutide API Price Forecast by Purity (2023-2028)

6 Market Size by Application

  • 6.1 Global Liraglutide API Sales by Application
    • 6.1.1 Global Liraglutide API Historical Sales by Application (2017-2022)
    • 6.1.2 Global Liraglutide API Forecasted Sales by Application (2023-2028)
    • 6.1.3 Global Liraglutide API Sales Market Share by Application (2017-2028)
  • 6.2 Global Liraglutide API Revenue by Application
    • 6.2.1 Global Liraglutide API Historical Revenue by Application (2017-2022)
    • 6.2.2 Global Liraglutide API Forecasted Revenue by Application (2023-2028)
    • 6.2.3 Global Liraglutide API Revenue Market Share by Application (2017-2028)
  • 6.3 Global Liraglutide API Price by Application
    • 6.3.1 Global Liraglutide API Price by Application (2017-2022)
    • 6.3.2 Global Liraglutide API Price Forecast by Application (2023-2028)

7 North America

  • 7.1 North America Liraglutide API Market Size by Purity
    • 7.1.1 North America Liraglutide API Sales by Purity (2017-2028)
    • 7.1.2 North America Liraglutide API Revenue by Purity (2017-2028)
  • 7.2 North America Liraglutide API Market Size by Application
    • 7.2.1 North America Liraglutide API Sales by Application (2017-2028)
    • 7.2.2 North America Liraglutide API Revenue by Application (2017-2028)
  • 7.3 North America Liraglutide API Sales by Country
    • 7.3.1 North America Liraglutide API Sales by Country (2017-2028)
    • 7.3.2 North America Liraglutide API Revenue by Country (2017-2028)
    • 7.3.3 United States
    • 7.3.4 Canada

8 Europe

  • 8.1 Europe Liraglutide API Market Size by Purity
    • 8.1.1 Europe Liraglutide API Sales by Purity (2017-2028)
    • 8.1.2 Europe Liraglutide API Revenue by Purity (2017-2028)
  • 8.2 Europe Liraglutide API Market Size by Application
    • 8.2.1 Europe Liraglutide API Sales by Application (2017-2028)
    • 8.2.2 Europe Liraglutide API Revenue by Application (2017-2028)
  • 8.3 Europe Liraglutide API Sales by Country
    • 8.3.1 Europe Liraglutide API Sales by Country (2017-2028)
    • 8.3.2 Europe Liraglutide API Revenue by Country (2017-2028)
    • 8.3.3 Germany
    • 8.3.4 France
    • 8.3.5 U.K.
    • 8.3.6 Italy
    • 8.3.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Liraglutide API Market Size by Purity
    • 9.1.1 Asia Pacific Liraglutide API Sales by Purity (2017-2028)
    • 9.1.2 Asia Pacific Liraglutide API Revenue by Purity (2017-2028)
  • 9.2 Asia Pacific Liraglutide API Market Size by Application
    • 9.2.1 Asia Pacific Liraglutide API Sales by Application (2017-2028)
    • 9.2.2 Asia Pacific Liraglutide API Revenue by Application (2017-2028)
  • 9.3 Asia Pacific Liraglutide API Sales by Region
    • 9.3.1 Asia Pacific Liraglutide API Sales by Region (2017-2028)
    • 9.3.2 Asia Pacific Liraglutide API Revenue by Region (2017-2028)
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 India
    • 9.3.7 Australia
    • 9.3.8 China Taiwan
    • 9.3.9 Indonesia
    • 9.3.10 Thailand
    • 9.3.11 Malaysia

10 Latin America

  • 10.1 Latin America Liraglutide API Market Size by Purity
    • 10.1.1 Latin America Liraglutide API Sales by Purity (2017-2028)
    • 10.1.2 Latin America Liraglutide API Revenue by Purity (2017-2028)
  • 10.2 Latin America Liraglutide API Market Size by Application
    • 10.2.1 Latin America Liraglutide API Sales by Application (2017-2028)
    • 10.2.2 Latin America Liraglutide API Revenue by Application (2017-2028)
  • 10.3 Latin America Liraglutide API Sales by Country
    • 10.3.1 Latin America Liraglutide API Sales by Country (2017-2028)
    • 10.3.2 Latin America Liraglutide API Revenue by Country (2017-2028)
    • 10.3.3 Mexico
    • 10.3.4 Brazil
    • 10.3.5 Argentina
    • 10.3.6 Colombia

11 Middle East and Africa

  • 11.1 Middle East and Africa Liraglutide API Market Size by Purity
    • 11.1.1 Middle East and Africa Liraglutide API Sales by Purity (2017-2028)
    • 11.1.2 Middle East and Africa Liraglutide API Revenue by Purity (2017-2028)
  • 11.2 Middle East and Africa Liraglutide API Market Size by Application
    • 11.2.1 Middle East and Africa Liraglutide API Sales by Application (2017-2028)
    • 11.2.2 Middle East and Africa Liraglutide API Revenue by Application (2017-2028)
  • 11.3 Middle East and Africa Liraglutide API Sales by Country
    • 11.3.1 Middle East and Africa Liraglutide API Sales by Country (2017-2028)
    • 11.3.2 Middle East and Africa Liraglutide API Revenue by Country (2017-2028)
    • 11.3.3 Turkey
    • 11.3.4 Saudi Arabia
    • 11.3.5 UAE

12 Corporate Profiles

  • 12.1 Suzhou Tianma Pharma Group
    • 12.1.1 Suzhou Tianma Pharma Group Corporation Information
    • 12.1.2 Suzhou Tianma Pharma Group Overview
    • 12.1.3 Suzhou Tianma Pharma Group Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.1.4 Suzhou Tianma Pharma Group Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 Suzhou Tianma Pharma Group Recent Developments
  • 12.2 Chengdu Shengnuo Biopharm
    • 12.2.1 Chengdu Shengnuo Biopharm Corporation Information
    • 12.2.2 Chengdu Shengnuo Biopharm Overview
    • 12.2.3 Chengdu Shengnuo Biopharm Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.2.4 Chengdu Shengnuo Biopharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Chengdu Shengnuo Biopharm Recent Developments
  • 12.3 Hangzhou Jiuyuan Gene Engineering
    • 12.3.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
    • 12.3.2 Hangzhou Jiuyuan Gene Engineering Overview
    • 12.3.3 Hangzhou Jiuyuan Gene Engineering Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.3.4 Hangzhou Jiuyuan Gene Engineering Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  • 12.4 Hybio Pharmaceutical
    • 12.4.1 Hybio Pharmaceutical Corporation Information
    • 12.4.2 Hybio Pharmaceutical Overview
    • 12.4.3 Hybio Pharmaceutical Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.4.4 Hybio Pharmaceutical Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 Hybio Pharmaceutical Recent Developments
  • 12.5 Dr. Reddy's Laboratories
    • 12.5.1 Dr. Reddy's Laboratories Corporation Information
    • 12.5.2 Dr. Reddy's Laboratories Overview
    • 12.5.3 Dr. Reddy's Laboratories Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.5.4 Dr. Reddy's Laboratories Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Dr. Reddy's Laboratories Recent Developments
  • 12.6 Rochem International Inc
    • 12.6.1 Rochem International Inc Corporation Information
    • 12.6.2 Rochem International Inc Overview
    • 12.6.3 Rochem International Inc Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.6.4 Rochem International Inc Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 Rochem International Inc Recent Developments
  • 12.7 ChemWerth Inc
    • 12.7.1 ChemWerth Inc Corporation Information
    • 12.7.2 ChemWerth Inc Overview
    • 12.7.3 ChemWerth Inc Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.7.4 ChemWerth Inc Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.7.5 ChemWerth Inc Recent Developments
  • 12.8 Bachem AG
    • 12.8.1 Bachem AG Corporation Information
    • 12.8.2 Bachem AG Overview
    • 12.8.3 Bachem AG Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.8.4 Bachem AG Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 Bachem AG Recent Developments
  • 12.9 CBL- Chemical and Biopharmaceutical Laboratories
    • 12.9.1 CBL- Chemical and Biopharmaceutical Laboratories Corporation Information
    • 12.9.2 CBL- Chemical and Biopharmaceutical Laboratories Overview
    • 12.9.3 CBL- Chemical and Biopharmaceutical Laboratories Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.9.4 CBL- Chemical and Biopharmaceutical Laboratories Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 CBL- Chemical and Biopharmaceutical Laboratories Recent Developments
  • 12.10 AmbioPharm
    • 12.10.1 AmbioPharm Corporation Information
    • 12.10.2 AmbioPharm Overview
    • 12.10.3 AmbioPharm Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.10.4 AmbioPharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.10.5 AmbioPharm Recent Developments
  • 12.11 Piramal Pharma Solutions
    • 12.11.1 Piramal Pharma Solutions Corporation Information
    • 12.11.2 Piramal Pharma Solutions Overview
    • 12.11.3 Piramal Pharma Solutions Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.11.4 Piramal Pharma Solutions Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.11.5 Piramal Pharma Solutions Recent Developments
  • 12.12 ALP Pharm
    • 12.12.1 ALP Pharm Corporation Information
    • 12.12.2 ALP Pharm Overview
    • 12.12.3 ALP Pharm Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.12.4 ALP Pharm Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.12.5 ALP Pharm Recent Developments
  • 12.13 Amphastar Pharmaceuticals
    • 12.13.1 Amphastar Pharmaceuticals Corporation Information
    • 12.13.2 Amphastar Pharmaceuticals Overview
    • 12.13.3 Amphastar Pharmaceuticals Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.13.4 Amphastar Pharmaceuticals Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.13.5 Amphastar Pharmaceuticals Recent Developments
  • 12.14 Amuna Pharmaceuticals LLP
    • 12.14.1 Amuna Pharmaceuticals LLP Corporation Information
    • 12.14.2 Amuna Pharmaceuticals LLP Overview
    • 12.14.3 Amuna Pharmaceuticals LLP Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.14.4 Amuna Pharmaceuticals LLP Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.14.5 Amuna Pharmaceuticals LLP Recent Developments
  • 12.15 Anthem Biosciences
    • 12.15.1 Anthem Biosciences Corporation Information
    • 12.15.2 Anthem Biosciences Overview
    • 12.15.3 Anthem Biosciences Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.15.4 Anthem Biosciences Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.15.5 Anthem Biosciences Recent Developments
  • 12.16 Aurobindo Pharma Limited
    • 12.16.1 Aurobindo Pharma Limited Corporation Information
    • 12.16.2 Aurobindo Pharma Limited Overview
    • 12.16.3 Aurobindo Pharma Limited Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.16.4 Aurobindo Pharma Limited Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.16.5 Aurobindo Pharma Limited Recent Developments
  • 12.17 Fresenius SE & Co. KGaA
    • 12.17.1 Fresenius SE & Co. KGaA Corporation Information
    • 12.17.2 Fresenius SE & Co. KGaA Overview
    • 12.17.3 Fresenius SE & Co. KGaA Liraglutide API Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.17.4 Fresenius SE & Co. KGaA Liraglutide API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.17.5 Fresenius SE & Co. KGaA Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Liraglutide API Industry Chain Analysis
  • 13.2 Liraglutide API Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Liraglutide API Production Mode & Process
  • 13.4 Liraglutide API Sales and Marketing
    • 13.4.1 Liraglutide API Sales Channels
    • 13.4.2 Liraglutide API Distributors
  • 13.5 Liraglutide API Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 14.1 Liraglutide API Industry Trends
  • 14.2 Liraglutide API Market Drivers
  • 14.3 Liraglutide API Market Challenges
  • 14.4 Liraglutide API Market Restraints

15 Key Finding in The Global Liraglutide API Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer